Amarilis Sanchez‐Valle

1.2k total citations
26 papers, 642 citations indexed

About

Amarilis Sanchez‐Valle is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Amarilis Sanchez‐Valle has authored 26 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Clinical Biochemistry, 12 papers in Physiology and 11 papers in Molecular Biology. Recurrent topics in Amarilis Sanchez‐Valle's work include Metabolism and Genetic Disorders (13 papers), Diet and metabolism studies (9 papers) and Mitochondrial Function and Pathology (5 papers). Amarilis Sanchez‐Valle is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Diet and metabolism studies (9 papers) and Mitochondrial Function and Pathology (5 papers). Amarilis Sanchez‐Valle collaborates with scholars based in United States, United Kingdom and Canada. Amarilis Sanchez‐Valle's co-authors include Krista Viau, Fran Rohr, Barbara K. Burton, Lorraine Potocki, Nicola Longo, Elaina Jurecki, Jessica Cohen‐Pfeffer, Stephen D. Cederbaum, Jerry Vockley and Stephanie Grünewald and has published in prestigious journals such as PEDIATRICS, Journal of Nutrition and The American Journal of Human Genetics.

In The Last Decade

Amarilis Sanchez‐Valle

25 papers receiving 634 citations

Peers

Countries citing papers authored by Amarilis Sanchez‐Valle

Since Specialization

Citations

This map shows the geographic impact of Amarilis Sanchez‐Valle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amarilis Sanchez‐Valle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amarilis Sanchez‐Valle more than expected).

Fields of papers citing papers by Amarilis Sanchez‐Valle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amarilis Sanchez‐Valle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amarilis Sanchez‐Valle. The network helps show where Amarilis Sanchez‐Valle may publish in the future.

Co-authorship network of co-authors of Amarilis Sanchez‐Valle

This figure shows the co-authorship network connecting the top 25 collaborators of Amarilis Sanchez‐Valle. A scholar is included among the top collaborators of Amarilis Sanchez‐Valle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amarilis Sanchez‐Valle. Amarilis Sanchez‐Valle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and efficacy of migalastat in adolescent patients with Fabry disease: Results from ASPIRE, a phase 3b, open-label, single-arm, 12-month clinical trial, and its open-label extension 2025 ·Molecular Genetics and Metabolism ·Uma Ramaswami, Esperanza Font–Montgomery, Özlem Göker-Alpan, Damara Ortiz, Amarilis Sanchez‐Valle, Chester B. Whitley, William R. Wilcox, Hai Jiang, Lee Ann Lawson, (unknown), Haichen Yang, Robert J. Hopkin	3
2	Lessons learned from 5 years of pegvaliase in US clinics: A case series 2024 ·Molecular Genetics and Metabolism Reports ·Erin E. Cooney, (unknown), (unknown), (unknown), (unknown), (unknown), Laura Davis‐Keppen, (unknown), (unknown), Stephanie Sacharow, Amarilis Sanchez‐Valle, (unknown), Bridget Wardley, (unknown), Hans C. Andersson	0
3	Elevated oxysterol and N‐palmitoyl‐O‐phosphocholineserine levels in congenital disorders of glycosylation 2023 ·Journal of Inherited Metabolic Disease ·An Dang, Irene J. Chang, (unknown), Lynne A. Wolfe, Bobby G. Ng, Christina Lam, Rhonda E. Schnur, (unknown), Hana Hansíková, Nina Ondrušková, (unknown), Amarilis Sanchez‐Valle, (unknown), Raymond Wang, (unknown), John Perreault, Daniel S. Ory, Hudson H. Freeze, J. Lawrence Merritt, Forbes D. Porter	4
4	Lower Urinary Tract Obstruction in Newborns 2023 ·Advances in Pediatrics ·(unknown), Amarilis Sanchez‐Valle, (unknown), (unknown), (unknown), Russell S. Kirby	2
5	Triheptanoin for the treatment of long‐chain fatty acid oxidation disorders: Final results of an open‐label, long‐term extension study 2023 ·Journal of Inherited Metabolic Disease ·Jerry Vockley, Barbara K. Burton, Susan A. Berry, Nicola Longo, John G. Phillips, Amarilis Sanchez‐Valle, Kimberly A. Chapman, Pranoot Tanpaiboon, Stephanie Grünewald, Elaine Murphy, Xiaoxiao Lu, (unknown), (unknown), (unknown), Laura Rosa Pisani, (unknown)	11
6	Neuropsychiatric Function Improvement in Pediatric Patients with Phenylketonuria 2023 ·The Journal of Pediatrics ·Mitzie Grant, Elaina Jurecki, Shawn E. McCandless, Stephen M. Stahl, Deborah A. Bilder, Amarilis Sanchez‐Valle, David Dimmock	2
7	OP017: Triheptanoin for the treatment of Long-Chain Fatty Acid Disorders (LC-FAOD): Final results of an open-label, long-term extension study 2022 ·Genetics in Medicine ·Jerry Vockley, Barbara K. Burton, Susan A. Berry, Nicola Longo, John G. Phillips, Amarilis Sanchez‐Valle, Kimberly A. Chapman, Pranoot Tanpaiboon, Stephanie Grünewald, Elaine Murphy, Xiaoxiao Lu, (unknown), (unknown), (unknown)	2
8	Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria: A seven-year analysis 2021 ·Molecular Genetics and Metabolism ·Susan E. Waisbren, Barbara K. Burton, Annette Feigenbaum, Laura Konczal, (unknown), Shawn E. McCandless, Richard Rowell, Amarilis Sanchez‐Valle, (unknown), Nicola Longo	11
9	Results from a 78‐week, single‐arm, open‐label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long‐chain fatty acid oxidation disorders (LC‐FAOD) 2019 ·Journal of Inherited Metabolic Disease ·Jerry Vockley, Barbara K. Burton, Gerard T. Berry, Nicola Longo, John G. Phillips, Amarilis Sanchez‐Valle, Pranoot Tanpaiboon, Stephanie Grünewald, Elaine Murphy, (unknown), Wencong Chen, (unknown), (unknown), Deborah Marsden, Emil Kakkis	45
10	Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria 2018 ·Genetics in Medicine ·Nicola Longo, David Dimmock, Harvey L. Levy, Krista Viau, (unknown), Deborah A. Bilder, Barbara K. Burton, (unknown), Hope Northrup, Fran Rohr, Stephanie Sacharow, Amarilis Sanchez‐Valle, (unknown), Janet A. Thomas, Jerry Vockley, Roberto T. Zori, Cary O. Harding	64
11	Adherence to clinic recommendations among patients with phenylketonuria in the United States 2017 ·Molecular Genetics and Metabolism ·Elaina Jurecki, Stephen D. Cederbaum, (unknown), (unknown), Fran Rohr, Amarilis Sanchez‐Valle, Krista Viau, (unknown), Jessica Cohen‐Pfeffer	135
12	UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24 weeks of treatment 2017 ·Molecular Genetics and Metabolism ·Jerry Vockley, Barbara K. Burton, Gerard T. Berry, Nicola Longo, John G. Phillips, Amarilis Sanchez‐Valle, Pranoot Tanpaiboon, Stephanie Grünewald, Elaine Murphy, Reed Humphrey, J. Mayhew, A. Bowden, (unknown), (unknown), Deborah Marsden, Emil Kakkis	58
13	Biliary Atresia 2017 ·Advances in Pediatrics ·Amarilis Sanchez‐Valle, Noor Kassira, (unknown), (unknown), Charles N. Paidas, Russell S. Kirby	60
14	A novel mutation in GLUD1 causing hyperinsulinism-hyperammonemia in a patient with high density of homozygosity on microarray: a case report 2016 ·Journal of Medical Case Reports ·(unknown), Maria Gieron‐Korthals, Dorothy I. Shulman, (unknown), Eloise J. Prijoles, Amarilis Sanchez‐Valle	3
15	Constitutional Chromoanagenesis of Distal 13q in a Young Adult with Recurrent Strokes 2016 ·Cytogenetic and Genome Research ·Rachel D. Burnside, (unknown), (unknown), W. Scott Burgin, David Z. Rose, Amarilis Sanchez‐Valle	5
16	A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria 2014 ·Molecular Genetics and Metabolism ·Barbara K. Burton, Mitzie Grant, Annette Feigenbaum, Rani H. Singh, Robert L. Hendren, Komudi Siriwardena, John A. Phillips, Amarilis Sanchez‐Valle, Susan E. Waisbren, Jane Gillis, Suyash Prasad, Markus Meriläinen, (unknown), (unknown), (unknown), Stephen M. Stahl	42
17	The severe end of the spectrum: Hypoplastic left heart in Potocki‐Lupski syndrome 2011 ·American Journal of Medical Genetics Part A ·Amarilis Sanchez‐Valle, Mary Ella Pierpont, Lorraine Potocki	27
18	Chronic Maternal Protein Deprivation in Mice Is Associated with Overexpression of the Cohesin-Mediator Complex in Liver of Their Offspring 2011 ·Journal of Nutrition ·Alfred Balasa, Amarilis Sanchez‐Valle, Bekim Sadiković, Haleh Sangi‐Haghpeykar, (unknown), Liang Chen, Wei Liu, Shu Wen, Marta L. Fiorotto, Ignatia B. Van den Veyver	7
19	HERV‐mediated genomic rearrangement of EYA1 in an individual with branchio‐oto‐renal syndrome 2010 ·American Journal of Medical Genetics Part A ·Amarilis Sanchez‐Valle, Xueqing Wang, Lorraine Potocki, Zhilian Xia, Sung‐Hae Kang, (unknown), (unknown), Patricia L. Williams, (unknown), Ellen K. Brundage, (unknown), Paweł Stankiewicz, Sau Wai Cheung, Seema R. Lalani	29
20	Identification of Uncommon Recurrent Potocki-Lupski Syndrome-Associated Duplications and the Distribution of Rearrangement Types and Mechanisms in PTLS 2010 ·The American Journal of Human Genetics ·Feng Zhang, Lorraine Potocki, Jacinda B. Sampson, Pengfei Liu, Amarilis Sanchez‐Valle, Patricia Robbins‐Furman, (unknown), Patricia G. Wheeler, J. Edward Spence, Campbell K. Brasington, Marjorie Withers, James R. Lupski	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact